Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024

2 weeks ago

TUSTIN, Calif., Sept. 03, 2024 ( GLOBE NEWSWIRE ) -- Avid Bioservices, Inc. ( NASDAQ:CDMO ) , a dedicated biologics contract development and manufacturing organization ( CDMO ) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, ...

Ticker	Sentiment	Impact
CDMO	Bullish	57 %